These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32970675)

  • 1. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
    Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
    Kulsoom H; Baig AM; Siddiqui R; Khan NA
    Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections Caused by Free-Living Amoebae.
    Kofman A; Guarner J
    J Clin Microbiol; 2022 Jan; 60(1):e0022821. PubMed ID: 34133896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Glucokinases from Pathogenic Free-Living Amoebae.
    Milanes JE; Suryadi J; Monaghan NP; Harding EM; Morris CS; Rozema SD; Khalifa MM; Golden JE; Phan IQ; Zigweid R; Abendroth J; Rice CA; McCord HT; Wilson S; Fenwick MK; Morris JC
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0237321. PubMed ID: 35604214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae".
    Baig AM
    Infect Disord Drug Targets; 2020; 20(2):115-121. PubMed ID: 30961516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
    Baig AM
    Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on
    Rice CA; Troth EV; Russell AC; Kyle DE
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32560115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular identification of Acanthamoeba spp., Balamuthia mandrillaris and Naegleria fowleri in soil samples using quantitative real-time PCR assay in Turkey; Hidden danger in the soil!
    Aykur M; Dagci H
    Acta Trop; 2023 Aug; 244():106956. PubMed ID: 37244403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic free-living amoebic encephalitis in Japan.
    Hara T; Yagita K; Sugita Y
    Neuropathology; 2019 Aug; 39(4):251-258. PubMed ID: 31243796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic free-living amoebae: epidemiology and clinical review.
    Trabelsi H; Dendana F; Sellami A; Sellami H; Cheikhrouhou F; Neji S; Makni F; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):399-405. PubMed ID: 22520593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic free-living amoebal pathogens.
    Mungroo MR; Khan NA; Maciver S; Siddiqui R
    Pathog Glob Health; 2022 Mar; 116(2):70-84. PubMed ID: 34602025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
    Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
    ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
    Visvesvara GS; Moura H; Schuster FL
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic amoebae: challenges in prophylaxis and treatment.
    Schuster FL; Visvesvara GS
    Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen
    Laurie MT; White CV; Retallack H; Wu W; Moser MS; Sakanari JA; Ang K; Wilson C; Arkin MR; DeRisi JL
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377287
    [No Abstract]   [Full Text] [Related]  

  • 17. The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.
    Phan IQ; Rice CA; Craig J; Noorai RE; McDonald JR; Subramanian S; Tillery L; Barrett LK; Shankar V; Morris JC; Van Voorhis WC; Kyle DE; Myler PJ
    Sci Rep; 2021 Nov; 11(1):21664. PubMed ID: 34737367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
    Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
    Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
    Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
    Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.
    Baig AM
    Curr Drug Targets; 2019; 20(1):60-69. PubMed ID: 29697029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.